Skip to main content

Protocol A

Type:
Prevalence / cross-sectional
Study Status:
Completed
Enrollment Status:
Completed
Countries:
Uganda;Kenya
Partners:
Kenya AIDS Vaccine Initiative-Kangemi (KAVI-Kangemi), Nairobi, Kenya; Kenya Medical Research Institute-Centre for Geographic Medicine Research-Coast (KEMRI-CGMRC), Kilifi, Kenya; Medical Research Council (MRC-Masaka)-Masaka, Uganda; Kakira-JCRC, Uganda.

 
Study Summary:
 
To estimate the number of individuals not infected with HIV who are available for a preventive HIV vaccine trial by measuring the prevalence of HIV infection in individuals who volunteer for this study.